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Abstract
The microbiome of the built environment (MoBE) is a relatively new area of study. While some knowledge has
been gained regarding impacts of the MoBE on the human microbiome and disease vulnerability, there is little
knowledge of the impacts of the MoBE on mental health. Depending on the specific microbial species involved,
the transfer of microorganisms from the built environment to occupant’s cutaneous or mucosal membranes has
the potential to increase or disrupt immunoregulation and/or exaggerate or suppress inflammation. Preclinical
evidence highlighting the influence of the microbiota on systemic inflammation supports the assertion that
microorganisms, including those originating from the built environment, have the potential to either increase or
decrease the risk of inflammation-induced psychiatric conditions and their symptom severity. With advanced
understanding of both the ecology of the built environment, and its influence on the human microbiome, it may
be possible to develop bioinformed strategies for management of the built environment to promote mental health.
Here we present a brief summary of microbiome research in both areas and highlight two interdependencies
including the following: (1) effects of the MoBE on the human microbiome and (2) potential opportunities for
manipulation of the MoBE in order to improve mental health. In addition, we propose future research directions
including strategies for assessment of changes in the microbiome of common areas of built environments shared
by multiple human occupants, and associated cohort-level changes in the mental health of those who spend
time in the buildings. Overall, our understanding of the fields of both the MoBE and influence of host-associated
microorganisms on mental health are advancing at a rapid pace and, if linked, could offer considerable benefit to
health and wellness.
Keywords: Bioinformed design, Built environment, Disease, Inflammation, Mental health, Microbiome,
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Background
The influence of the built environment on the mental
health of building occupants has been documented in-
cluding relationships between housing quality, occupant
density, noise, indoor air quality, and mental health [1].
One major relationship not yet elucidated is the connec-
tion between indoor microorganisms and the mental
health of human occupants. Recent advances in DNA
sequencing technologies and associated cost savings
have led to an expansion of research on microorganisms
observed indoors, collectively called the microbiome of
the built environment (MoBE). Led in part by the
contributions and organization of the Alfred P. Sloan
Foundation, building scientists and microbial ecologists
are collaborating to (1) investigate the influence of archi-
tecture on the MoBE [2, 3], (2) establish a community of
cross-disciplinary researchers [4], and (3) develop tools
required for data analysis and visualization [5, 6]. To our
knowledge, the MoBE has yet to be evaluated with re-
spect to mental health outcomes.
Preclinical evidence strongly supports the important
influence of the human microbiome (e.g., microorgan-
isms localized to the gut, skin, and other organs) on
systemic inflammation [7–11], autoimmunity [12], blood-
brain barrier function [13], neuroinflammation [14], cog-
nitive function [15, 16], and emotional behavior [16–19].
Specifically, there is an increasing appreciation regarding
the potential association between inflammation and
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mental health, ranging from wellness to neuropsychi-
atric disease [20–24]. This association is of concern as
evidence suggests that chronic inflammatory disorders
are increasing in high-income countries. One factor
contributing to this increase is thought to be failing im-
munoregulation, attributable to reduced exposure to the
microbial environment within which the mammalian
immune system co-evolved [23]. We, along with others,
have proposed that faulty immunoregulation is also driv-
ing increases in some psychiatric disorders [23, 25–27].
The full development of secondary lymphoid tissues
and a diverse lymphocyte repertoire after birth requires
signals from microbial components [28], while further
microbial signals later in life drive balanced expansion
of effector T cell populations [29] and regulatory T cells
[30, 31]. The organisms most responsible for these
effects are those with which mammals co-evolved, in-
cluding the following: (1) the commensal/symbiotic
microbiota [30, 31]; (2) certain “old infections,” includ-
ing Helicobacter species, that were present throughout
life in evolving human hunter-gatherer populations
[25, 32]; and (3) organisms from the natural environment
with which humans were inevitably in daily contact
throughout evolution [33–35]. Immunoregulation is com-
promised in modern high-income settings in part because
contact with these three categories of immunoregulatory
organisms is reduced [25].
Several society-level shifts, such as those noted below,
have and will continue to lead to an increasing disconnect
between humans, the outdoor environment, and the mi-
croorganisms with which humans co-evolved [36–38].
In the USA, individuals typically spend nearly 90 % of
their time in the built environment [39]. Comforts, such
as air conditioning, have made geographic locations
more hospitable for year-round living in the indoor en-
vironment and will likely drive increased time spent in
the built environment [40]. Residential homes built in
set parcels for subdivisions have an architecture that is
typically not conducive to natural heating and cooling.
To reduce energy costs, design and subsidized weatheri-
zation programs can further reduce outdoor exposures
by making the homes less leaky and lowering air ex-
change rates [41]. This issue may be relevant to devel-
oping, as well as developed, countries. Migration from
rural to urban environments in developing countries is
occurring at a rapid pace [42], and it could lead to a re-
duction in exposure to environmental microorganisms,
as already seen in industrialized nations.
One popular model for conceptualizing the onset of
psychiatric disorders is the stress-diathesis model [43,
44]. The model suggests that individuals have biopsycho-
social vulnerabilities for developing mental health ill-
nesses (diathesis) that can be realized through stressors.
We contend that model has parallels to a model for un-
healthy buildings (Fig. 1). That is, an unhealthy building
can have design or operational flaws (diathesis) that
under specific circumstances (stressors) create a predis-
position to poor indoor air quality for the occupants.
For example, sick building syndrome is a term used to
describe an unhealthy building in which occupants living
and working in that space are found to be suffering from
acute negative outcomes which are not linked to a spe-
cific cause. This article expands upon how the MoBE
and mental health fields can and should be integrated.
Specifically, we will investigate (1) the effects of the
MoBE on the human microbiome and (2) potential op-
portunities for manipulation of the MoBE in order to
improve mental health. In addition, we will propose
Fig. 1 Parallels between individual diathesis-stress model (a) and potential unhealthy building model (b). Note that this comparison is not all
inclusive of factors or triggers in either model
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future research directions, including strategies for as-
sessment of changes in the microbiome of common
areas of built environments shared by multiple human
occupants and associated cohort-level changes in the
mental health of those who spend time in the building.
The purpose of this review is to initiate discussions that
build new research efforts between building scientists,
microbial ecologists, and clinical research psychologists
and psychiatrists.
Review
Microbial exposures early in life can have long-lasting
impacts on the immune system including reducing in-
flammatory responses in adulthood [45]. One potential
connection between the MoBE and mental health could
be the influences of the MoBE on the human micro-
biome. For that influence to occur, it must be shown
that microorganisms in the built environment are trans-
ferred to occupants. Researchers have also determined
that reciprocal interactions occur between the host im-
mune system and host microbiome. In a murine model,
altered immune status, either induced by antagonism of
complement component 5a receptor 1 (C5aR) or as ob-
served in immunocompromised mice, was associated
with decreases in host-associated skin microbial diversity
and altered microbial community structure [46, 47]. Ac-
tivation of the complement system typically functions as
a defense mechanism against invading microorganisms,
in part because C5a “primes” phagocytic cells and
optimizes innate immune functional responses. Thus, as
expected, altering the host immune response to microor-
ganisms alters the host-associated microbial diversity
and community structure. With the expansion of the
biological field beyond traditional culturing, it is now
clear that microbial residue can persist in the environ-
ment past a viable cell life [48, 49]. Indeed, microorgan-
isms or microbial antigens, in addition to live, intact
microorganisms, are sufficient to have important impacts
on systemic immune function and inflammatory disease.
For example, heat-killed preparations of mycobacteria
have been shown to confer protection in allergy models
[50]. In other words, there are reciprocal relationships
between the host-associated microbiota and host im-
mune function, and microorganisms do not have to
be living, or even intact, in order to have important
influences on health outcomes. This may be of inter-
est to MoBE researchers who, to date, have used
DNA sequencing that does not distinguish between
live, dead but intact, or dead and structurally com-
promised microorganisms. However, methods using
compounds like propidium monoazide (PMA) have
shown promise for making these distinctions in qPCR
studies [51–53]. Additionally, Kelley and Gilbert [48]
suggested mRNA as a sequencing target to distinguish
between live and dead microorganisms because RNA
is rapidly degraded in the environment.
Current research has focused on how occupants alter
the MoBE and have documented the transmission of
microorganisms from human occupants to the air and
surfaces within buildings [2, 3, 54–59]. Human skin
microorganisms are likely a major source of indoor
human-related microorganisms and have been observed
in the MoBE in classrooms [60], households [57], and
athletic environments [55]. The human occupants de-
posit skin microorganisms at a rate of 106 airborne mi-
crobial cells per hour [61], but these microorganisms
can decay and are replaced at a rapid rate on surfaces
commonly in contact with humans [56]. Whereas the
cutaneous membrane is completely exposed to the envir-
onment [62], mucosal surfaces of the bronchopulmonary
system, gastrointestinal system, and genitourinary sys-
tem each have their own microbiota, with potential for
contributions from exposure to microorganisms from
the MoBE [63–65]. The skin, mucosal surfaces, and the
immune system are in constant communication to pro-
mote homeostasis in the human microbiome [11, 66,
67]. Research is sparse on whether these microbial com-
munities, transferred from occupants to the air and sur-
faces within a building, are conveyed to other occupants.
We think it is important to identify whether the existing
MoBE can alter the occupants’ microbiome and, subse-
quently, mental health.
Studies that document transmission of microorgan-
isms from reservoirs within the built environment to hu-
man occupants have historically focused on pathogens.
For instance, nontuberculous mycobacteria (NTM) iso-
lates recovered from water systems and showers have
been matched to clinical isolates of NTM [68, 69]. Simi-
larly, room humidifiers, whirlpools, air conditioning
systems, and other sources have been identified as the
indoor microbial reservoirs responsible for Legionella in-
fections of human occupants [70–72]. While some in-
door sources such as humidifiers provide a direct route
of microbial transfer to humans [73, 74], other transfers
can be more complex. For instance, in some cases, mi-
croorganisms such as Staphylococcus aureus originate
from a human source but appear to spend time in an in-
door reservoir before being transmitted back to other
human occupants [75]. Thus, microorganisms can be
transferred to and from occupants and environmental
reservoirs within buildings but the level of bidirectional
transmission for many microorganisms and microbial
communities remains unknown. Of course, transmission
of microorganisms from one human occupant to the
next is also possible [76, 77], and this further compli-
cates the analysis.
A practical consequence of improved understanding
of relationships among the MoBE, host-associated
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microbiota, and mental health could be the develop-
ment of a bioinformed design in the built environment
(see commentary by Green [78]) to prevent negative
mental health-related outcomes. This could be analo-
gous to how access to green spaces can improve mental
health outcomes [33]. Moreover, studies in rodents sug-
gest that bioimmunomodulatory probiotics (e.g., Lacto-
bacillus reuteri) have stress-protective effects and can
reduce negative outcomes of gastrointestinal infections
[16]. Preliminary results in mice suggest these probio-
tics can reduce anxiety and fear following oral or intra-
venous administration. Building materials or the built
environment could be designed to facilitate exposure of
human occupants to these types of beneficial probiotics.
Probiotics in these instances might extend beyond a few
microorganisms and instead include diversity in micro-
bial communities. Microbial diversity has been linked to
positive health outcomes, even if the causative agents
are not yet delineated [79].
Research on microbial growth on different building
materials is now being considered beyond moisture-
damaged materials [80–82], but more studies are
required to fully evaluate the range of construction
practices and building types. The development of such
a database of materials that support growth of benefi-
cial microorganisms, in addition to those that support
growth of potentially harmful microorganisms, would
be of value to the community of researchers. However,
to develop that database, knowledge of which microor-
ganisms are beneficial is required. In the context of
this review on mental health, we provide a summary in
Table 1 of microorganisms that have been linked to
positive mental health outcomes. In addition to mate-
rials, selection of microorganisms for bio-mediated
construction procedures is a relatively new field in the
last 10 years and could provide benefits for a bioin-
formed built environment.
However, as noted by Green, research to date is not
yet sufficient to define interactions between microorgan-
isms and the built environment, and the effects that ma-
nipulation of the MoBE could have on the occupants.
Indeed, only recently have we begun to realize that
indiscriminant sterilization of the built environment is
not beneficial to occupants [83–85]. The science of ei-
ther seeding the indoor environment with beneficial mi-
croorganisms or providing conditions that promote
selective microbial growth is likely a distant reality in
practice, and considerable research is required before re-
searchers can recommend such practices. Any modifica-
tions would need to consider factors such as geographic
location, seasons, building characteristics, occupant ages,
health status, and behavior, and likely many other factors
yet to be determined. Future work in this direction could
provide considerable benefit in terms of mental health
wellness. However, as noted by Logan [86], additional
adverse environmental factors in urban environments,
coined the gray space, could reduce the mental health
benefits of changing the MoBE, especially in relation
to those individuals who are socioeconomically disad-
vantaged. An example of an understudied topic is the
interaction between the MoBE and the host-associated
microbiomes among individuals living or working in
close proximity. An initial study of a family observed
homogenization of the gut microbiome across family
members, at least in comparison to non-family mem-
bers [87].
Given the importance of inpatient care on mental
health, one specific built environment of interest in the
relationship between microbiomes of the built environ-
ment is that of the hospital. Recently, a collaboration led
by the University of Chicago has systematically explored
the microbiome in a Chicago hospital from conception
through the first year of operation [83]. The results of
that work are not yet published, but other articles have
identified methods to control microbial spread in a
hospital environment including ventilation strategies
[88, 89], cleaning techniques [90–92], and use of UV
lamps [93–96]. Interestingly, since we do not have a
clear understanding of the role of the built environ-
ment microbiome on mental health, it is impossible to
state if those listed control measures and others are
beneficial or harmful to the occupant. Additional re-
search on the influence of the gut and non-gut micro-
biomes and mental health is required to provide better
designs in hospital and treatment centers.
With a better understanding of the interactions be-
tween the MoBE and the host-associated microbiota of
human occupants, research could proceed to identifica-
tion of environmental microorganisms that are either
beneficial or harmful to the mental health of individuals,
thereby mitigating potential diatheses or stressors. Hu-
man microbial communities differ across the body, but
identification of an individual by their microbial finger-
print can still be achieved through multi-kingdom meta-
genomics sequencing with an accuracy of over 80 %
[62]. Therefore, if certain MoBE markers are determined
to contribute to mental health conditions, researchers
could use sampling of the built environment to detect
potential negative mental health conditions of individ-
uals in that environment. Identification of associations
between occupants and the microbiome of their sur-
roundings or personal items, referred to as microbiome
fingerprinting, may be possible in the future. Lax et al.
[97] utilized a supervised learning algorithm to success-
fully predict if a 16S rRNA sample was from a phone or
a shoe. They sampled at three different geographically
separated conferences and were able to predict which
conference the samples were from. Another study of
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Table 1 Beneficial microorganisms in mental health studies found in the built environment
Phylum/microorganism Model Environmental sources Presence in MoBE Mental health relevant findingsa
Actinobacteria
Mycobacterium vaccae Human Environmental saprophyte
(soil, mud, water, grasses,
decaying organic matter)
[119–125]
Soil floors [123], reservoirs [125], well water [122, 126],
cooling towers [126, 127], water distribution systems [128],
household tap water [126, 129], moisture-damaged build-
ing materials [130], terraria [131], sewage [122], drainage
pools [132], wastewater treatment plants [133]
Increased cognitive function, decreased pain in patients
with advanced non-small-cell lung cancer [134]
Mouse Activation of brain serotonergic systems and
antidepressant-like behavioral effects [135]; decreased
anxiety/increased cognitive function [136]
Bifidobacterium breve Mouse Human commensal Human and animal wastewater, wastewater treatment
plants [137]
Increased cognitive function [138]; decreased anxiety-
related behaviors [139]
Bifidobacterium infantis Rat Human commensal Human and animal wastewater, wastewater treatment
plants [137]
Reversal of depressive-like behavior following maternal
separation [140]
Bifidobacterium longum Human Human commensal Human wastewater, wastewater treatment plants [137] Decreased anxiety and depressive symptoms in healthy
volunteers (administered with L. helveticus) [141, 142]
Mouse Decreased-colitis associated anxiety [143, 144]; increased
cognitive function [138]; decreased stress, anxiety- and
depression-related behaviors [139]
Bacteroidetes
Bacteroides fragilis Mouse Human commensal Human and animal wastewater, wastewater treatment
plants [145]
Developmental protection from some of the behavioral
symptoms associated with autism spectrum disorder [146]
Firmicutes
Clostridium butyricum Human Endospore-forming soil
bacterium
Anxiolytic effects [147]
Enterococcus faecium Mouse Human commensal,
wetlands [148]
Well water, human and animal wastewater, wastewater
treatment plants [148]
Increased brain antioxidant markers [149]
Lactobacillus casei Human Human commensal,
fermented foods [150]
Human and animal wastewater, wastewater treatment
plants [150], office space (Lactobacillus spp.), bathroom
surfaces (Lactobacillaceae) [151]
Improvement in anxiety symptoms in patients with chronic
fatigue syndrome [152]; improved mood [153]




Sewage [155], office space (Lactobacillus spp.) [156],
bathroom surfaces (Lactobacillaceae) [151]
Decreased anxiety and inhibition of antibiotic-induced
cognitive impairment [157]
Lactobacillus helveticus Human Fermented foods [150] Office space (Lactobacillus spp.) [156], bathroom surfaces
(Lactobacillaceae) [151]
Decreased anxiety and depressive symptoms in healthy
volunteers (administered with B. longum) [141, 142]
Rat Improved cognitive function, decreased anxiety-related
behavior [158]; prevention of stress-induced cognitive
impairment and anxiety- and depressive-like responses
[159]
Mouse Decreased anxiety-related behavior [160]; improved
cognitive function, decreased anxiety-related behavior
(administered with L. rhamnosus) [15, 161]
Lactobacillus pentosus Fermented foods [150] Sewage [155], office space (Lactobacillus spp.) [156],
bathroom surfaces (Lactobacillaceae) [151]












Table 1 Beneficial microorganisms in mental health studies found in the built environment (Continued)
Lactobacillus reuteri Human Human commensal,
fermented foods [150]
Office space (Lactobacillus spp.) [156], bathroom surfaces
(Lactobacillaceae) [151]
Increased workplace healthiness [163]
Lactobacillus rhamnosus Mouse Human commensal,
fermented foods [150]
Sewage [155], office space (Lactobacillus spp.) [156],
bathroom surfaces (Lactobacillaceae) [151]
Vagus nerve-dependent alterations in GABA receptor
mRNA expression in brain, reduced anxiety- and
depression-related behavior [17]; improved cognitive
function, decreased anxiety-related behavior (administered
with L. helveticus) [161, 164]
Probiotic cocktails
B. bifidum, B. lactis, L. acidophilus, L.
brevis, L. casei, L. salivarius, L. lactis
Human Reduced cognitive reactivity to sad mood [165]
B. animalis subsp. Lactis, Streptococcus
thermophilus, L. bulgaricus, L. Lactis
subsp. Lactis
Human Altered task-related response of brain networks involving
affective, viscerosensory, and somatosensory cortices [166]
L. acidophilus, B. lactis Human Improved scores on anxiety, depression, and stress scales
[167]
L. casei, L. acidophilus, L. rhamnosus, L.
bulgaricus, B. breve, B. longum, S.
thermophilus
Human Improved scores on anxiety, depression, and stress scales
[167]
VSL#3: S. salivarius subsp.
thermophilus, B. breve, B. infantis, B.
longum, L. acidophilus, L. planarum, L.
casei, L. delbrueckii subsp. bulgaricus
Mouse Decreased sickness behavior, decreased microglial
activation [168]
L. plantarum, L. curvatus Rat Improved cognitive function [169]
L. acidophilus, B. lactis, L. fermentum Rat Improved cognitive function [170]
L. helveticus, B. longum Rat Decreased depressive-like behavior [171]












phones sampled the microbiome of both the phones and
fingerprints and observed that 82 % of the dominant
bacterial sequences was shared between a user and their
phone [98]. Using the human microbiome project data-
set, by averaging microbiomes over all 18 body sites, and
by developing a metagenomic code, Franzosa et al. [99]
determined that approximately 30 % of sequences were
matched between two sampling events 30 to 300 days
apart. The most stable microbiome was the gut, which
likely does not significantly contribute to the MoBE out-
side of restrooms. As noted by that study, research on
how the individual microbiomes differ across anatomical
sites and longitudinally over time will be crucial for fu-
ture microbiome fingerprinting efforts.
One important under-recognized contributory role to
the MoBE is that of pets. Their microbiome is known to
interact with that of their owners. Exposure to pets dur-
ing childhood has been associated with lower prevalence
of allergic disease, potentially through increased pet-
driven indoor exposure to saprophytic soil organisms
with immunomodulatory potential (see Table 1). How-
ever, pets also carry indoors microorganisms with po-
tential long-term detrimental effects on mental health.
For example, Toxoplasma gondii (T. gondii) is a highly
prevalent neurotropic parasite establishing latency in all
warm-blooded animals including humans. In immuno-
suppressed patients and during pregnancy its effects can
be devastating. In immunocompetent hosts “latent” T.
gondii infection has been associated with mental illness
[100] and suicide [101]. Even in individuals with no evi-
dence of mental illness, T. gondii seropositivity has been
associated with gender-specific trait impulsivity and ag-
gression [102]. Infection with T. gondii occurs via inges-
tion of tissue bradyzoites from inadequately cooked/
processed meat, or via transmition of oocysts through
exposure to cat litter or contaminated soil [103]. Cats,
the permanent hosts of T. gondii, are implicated in the
direct fecal transmission of the microorganism; preg-
nant women are advised to avoid exposure to domestic
cat litter. Moreover, dogs carry oocysts indoors on their
fur by seeking-out and rolling in cat feces and contami-
nated soil [104].
An extension of microbiome fingerprinting could
involve examining the influence of stress on the hu-
man microbiome and MoBE. Individuals suffering
from psychiatric disorders may have physiological
differences that affect the skin [105] and mucosal
[106, 107] microbiomes, which in turn may alter the
MoBE. For example, Biagi et al. [108] found that
9 % of the total variability seen in the gut micro-
biome was related to proinflammatory cytokines IL-6
and IL-8, with this effect being predominately driven
by Proteobacteria. As noted, a feedback loop be-
tween occupants, the built environment, and other
occupants has been shown in nosocomial infections.
That same feedback loop is likely occurring for non-
pathogens although not as well studied to date.
Nosocomial pathogens like Staphylococcus aureus,
Mycobacterium tuberculosis, and Clostridium difficile
can remain viable on dry surfaces for months [109, 110],
although as already noted, microorganisms do not have to
be viable to contribute to health outcomes.
Conclusions
Despite the massive effort in the human microbiome
project, researchers observed that variation in the
healthy human microbiome was not well correlated with
biometrics (gender, body temperature, blood pressure,
etc.) and concluded that other factors might be important
[111]. One such factor could be the MoBE that surrounds
individuals. It is likely that the MoBE alters immune sys-
tem function through influences on the host-associated
microbiota and, therefore, could have an effect on the
mental health of the occupants as presented in Fig. 1.
Study designs developed by mental health professionals,
building scientists, and microbial ecologists should begin
to critically evaluate that idea. Furthermore, given the re-
cent interest in the microbiome-gut-brain axis [112–115],
if the MoBE does alters the gut microbiota, considerable
research opportunities could follow for future studies of
the relationships among the microbiota of the built envir-
onment, the host-associated microbiota, and mental
health with the aim of intervening to decrease negative
health-related outcomes. It is possible that intentional
modification of the built environment to increase micro-
bial biodiversity, or to increase exposure to immunoregu-
latory antigens or probiotics, would result in improved
mental health conditions. Moreover, mental health and
MoBE studies logically extend to autism spectrum disor-
ders and other neurodevelopmental disorders, such as
schizophrenia, that have been investigated with a human
microbiome perspective [116–118].
There is credible evidence that these two fields, if
linked, could improve future mental health outcomes
for both the community at large (e.g., prevention), as
well as those with psychiatric disorders (intervention).
Research studies will provide the most benefit if dis-
cussions among investigators with multiple specialties
are initiated in the study design phase. With a com-
bined effort between the MoBE consortia and mental
health professionals, a greater understanding of the
relationship between the MoBE, the microbiome of
human occupants, and mental health can occur at a
more rapid pace.
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